Lucid Diagnostics Inc. (LUCD)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 02:51PM EDT. Market open.
| Previous close | 0.8900 |
| Open | 0.8900 |
| Bid | 0.8772 x 100 |
| Ask | 0.9100 x 100 |
| Day's range | 0.8800 - 0.9099 |
| 52-week range | 0.6300 - 1.8500 |
| Volume | |
| Avg. volume | 225,919 |
| Market cap | 47.419M |
| Beta (5Y monthly) | 1.49 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.2600 |
| Earnings date | 26 Mar 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 3.83 |
- GuruFocus.com
Lucid Diagnostics Inc (LUCD) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and ...
Discover how Lucid Diagnostics Inc (LUCD) is navigating its financial landscape and strategic initiatives in the first quarter of 2024.
PR NewswirePAVmed Provides Business Update and First Quarter 2024 Financial Results
PAVmed Inc. (NASDAQ: PAVM, PAVMZ) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today provided a business update for the Company and its subsidiaries, Lucid Diagnostics Inc. (NASDAQ: LUCD) ("Lucid") and Veris Health Inc. ("Veris"), and presented financial results for the Company for the three months ended March 31, 2024.
© 2024 Yahoo. All rights reserved.